Used in the synthesis of fluorinated pharmaceutical intermediates, particularly in the development of chiral active pharmaceutical ingredients (APIs). Its structure supports the creation of beta-adrenergic receptor agonists and other central nervous system-targeting drugs. The compound's chirality makes it valuable in asymmetric synthesis where stereochemical purity is critical. Commonly employed in research settings for developing novel therapeutic agents with improved selectivity and metabolic stability.